HomeInsightsPE

Akums Drugs & Pharmaceuticals Ltd PE Ratio

Akums Drugs & Pharmaceuticals Ltd PE Ratio

stocks purchased

₹ 1.0 Cr

Volume Transacted

(Dec 11, 2024)

stocks purchased

16.4 K

Stocks Traded

(Dec 11, 2024)

Last Updated on: Dec 11, 2024

Image

Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS

PE

35.2

Last updated on: Dec 11, 2024

Key Highlights

  • The P/E Ratio of Akums Drugs & Pharmaceuticals Ltd is 35.2 as of 11 Dec 15:30 PM .
  • The P/E Ratio of Akums Drugs & Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Latest Trading Price of Akums Drugs & Pharmaceuticals Ltd is ₹ 612.45 as of 11 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Akums Drugs & Pharmaceuticals Ltd

No data available

Company Fundamentals for Akums Drugs & Pharmaceuticals Ltd

No data available

Image

Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS

Share Price

₹ 612.45

0.00 (0.00%)

stock direction

Last updated on: Dec 11, 2024

Market Price of Akums Drugs & Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Akums Drugs & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
10 Dec 2024612.45
09 Dec 2024624.55
06 Dec 2024624.35
05 Dec 2024609.05
04 Dec 2024611.65
03 Dec 2024623.65
02 Dec 2024617.3
29 Nov 2024605.4
28 Nov 2024606.45
27 Nov 2024638.35

BlinkX Score for Akums Drugs & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Akums Drugs & Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Akums Drugs & Pharmaceuticals Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payout of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in %

About Akums Drugs & Pharmaceuticals Ltd

  • Akums Drugs and Pharmaceuticals Limited was incorporated vide Certificate of Incorporation dated April 19, 2004 and received a Certificate for Commencement of Business dated May 13, 2004 issued by the RoC. Alkums Drugs & Pharmas are a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
  • They are into sale of branded pharmaceutical formulations and manufacturing of Active Pharmaceutical Ingredients.
  • Some of the other services include formulation research and development, preparation and filing of regulatory dossiers into the Indian and global markets, and other testing services.
  • Some of manufacturing units have been accredited by various global regulatory agencies such as the European Good Manufacturing Practice, the World Health Organization Good Manufacturing Practice and the United States National Sanitation Foundation.

Akums Drugs & Pharmaceuticals Ltd News Hub

News

Akums Drugs and Pharmaceuticals rises on debut

The scrip was listed at Rs 725, exhibiting a 6.77% premium to the issue price. So far, the...

Read more

2024-08-06 00:00:00

News

Akums Drugs and Pharmaceuticals IPO ends with strong subscription

The initial public offer (IPO) of Akums Drugs and Pharmaceuticals received 96,36,79,134 bi...

Read more

2024-08-02 00:00:00

News

Akums Drugs and Pharmaceuticals IPO subscribed 63.44 times

The initial public offer (IPO) of Akums Drugs and Pharmaceuticals received 96,18,57,204 bi...

Read more

2024-08-01 00:00:00

News

Akums Drugs & Pharmaceuticals reports consolidated net profit of Rs 60.17 crore in the June 2024 quarter

Net profit of Akums Drugs & Pharmaceuticals reported to Rs 60.17 crore in the quarter ende...

Read more

2024-08-26 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Akums Drugs & Pharmaceuticals Ltd

What is the current PE Ratio of Akums Drugs & Pharmaceuticals Ltd?

The Current PE Ratio of Akums Drugs & Pharmaceuticals Ltd is 35.18 as on 11 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 11 Dec 2024.

What was the PE Ratio of Akums Drugs & Pharmaceuticals Ltd last year?

The PE Ratio of Akums Drugs & Pharmaceuticals Ltd was 0.0 last year, now the PE ratio is 35.18, showing a year-on-year growth of -%.

What does the PE Ratio of Akums Drugs & Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Akums Drugs & Pharmaceuticals Ltd is 35.18. This ratio indicates that investors are willing to pay 35.18 times the earnings per share for each share of Akums Drugs & Pharmaceuticals Ltd.

What is the PE Ratio Growth of Akums Drugs & Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Akums Drugs & Pharmaceuticals Ltd grew by -% whereas, the EPS ratio grew by 3.8.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions